Asean PRESS RELEASES

CORRECTION FROM SOURCE: Transport Canada Certifies 90-Seat Cabin Configuration for Bombardier’s Q400 Aircraft

Launch customer SpiceJet of India to become first airline to take advantage of the extra-capacity turboprop’s increased profitability potential TORONTO, Aug. 01, 2018 (GLOBE NEWSWIRE) — This document corrects and replaces the press release that was sent today at 9:00 am EDT. Bombardier Commercial Aircraft announced today that its 90-passenger Q400 aircraft configuration has received […]

Asean PRESS RELEASES

Williams Scotsman to Announce Second Quarter 2018 Results on August 7, 2018

BALTIMORE, Aug. 01, 2018 (GLOBE NEWSWIRE) — WillScot Corporation (Nasdaq: WSC) (“Williams Scotsman”) today announced that it will release its second quarter 2018 financial results Tuesday, August 7, 2018 after the markets close. President and Chief Executive Officer, Brad Soultz, and Chief Financial Officer, Tim Boswell, will host a conference call and webcast on Wednesday, August 8, 2018 at 10:00 […]

Asean PRESS RELEASES

Williams Scotsman to Announce Second Quarter 2018 Results on August 7, 2018

BALTIMORE, Aug. 01, 2018 (GLOBE NEWSWIRE) — WillScot Corporation (Nasdaq: WSC) (“Williams Scotsman”) today announced that it will release its second quarter 2018 financial results Tuesday, August 7, 2018 after the markets close. President and Chief Executive Officer, Brad Soultz, and Chief Financial Officer, Tim Boswell, will host a conference call and webcast on Wednesday, August 8, 2018 at 10:00 […]

Asean PRESS RELEASES

CORRECTING and REPLACING — Neuralstem, Inc.

GERMANTOWN, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) — In a release issued yesterday by Neuralstem, Inc. (Nasdaq:CUR), please note the headline should be, “Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-566 in Ischemic Stroke,” rather than, “Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-189 in Ischemic Stroke,” as originally issued. The corrected […]

Asean PRESS RELEASES

CORRECTING and REPLACING — Neuralstem, Inc.

GERMANTOWN, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) — In a release issued yesterday by Neuralstem, Inc. (Nasdaq:CUR), please note the headline should be, “Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-566 in Ischemic Stroke,” rather than, “Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-189 in Ischemic Stroke,” as originally issued. The corrected […]